ArticleJournal of feline medicine and surgery2026
Surgical treatment of feline meningioma: a single-institution survival analysis.
Article in Journal of feline medicine and surgery, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Transcriptomic Challenges We Faced with Animal Models for Neurological Disorders.Current issues in molecular biology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Case series summaryThe aim of this study was to evaluate median survival time (MST), disease-free interval (DFI) and postoperative complications of surgical resection of feline intracranial meningiomas, providing evidence for prognostic counselling for general practitioners. A retrospective review of medical records (2012-2025) identified 17 cats undergoing craniotomy or craniectomy for histologically confirmed meningiomas. Data included patient characteristics, clinical signs, imaging findings, surgical approach, complications, histopathology, recurrence and survival. MRI or CT was used for diagnosis and postoperative monitoring when available. Survival analysis employed Kaplan-Meier and competing risk models; DFI was based on clinical signs or follow-up imaging. A total of 17 cats (median age 11.6 years; 82.4% domestic shorthairs) underwent surgery. The rostrotentorial approach was most common (65%), with minor intraoperative complications in three cases. Postoperative mortality within 4 weeks was 17.6% (3/17). In total, 14 cats survived to discharge. Median follow-up was 622 days. Estimated MST was 1674 days (95% confidence interval [CI] 1395-NE [not estimable]), with 1-, 2-, 3- and 4-year survival rates of 82%, 82%, 82% and 72%, respectively. Median DFI was 377 days (855 days for cats surviving to discharge). Histopathology predominantly included meningothelial and transitional subtypes. Recurrence was detected on MRI in 3/6 cases undergoing follow-up imaging.Relevance and novel informationSurgical resection of feline meningiomas is a feasible treatment option with excellent outcomes for cats surviving the immediate postoperative period. The study demonstrates a high MST and low recurrence rate among treated cats, with surgery being curative in many cases. These results enable the veterinary general practitioner to more accurately assess the risks and benefits of surgical treatment of feline intracranial meningioma and discuss treatment with owners.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.